# US 2024/0307577 A1 · Chlorinated 4'-alkylumbelliferyl alpha-d-glucopyranoside and method of assessing efficacy of a sterilization process including the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0307577 A1
- Document ID: US20240307577A1
- Status: Published application
- Kind: A1
- Application number: 18/576,785
- Filed: 2022-07-18
- Published: 2024-09-19
- Earliest claimed: 2021-07-22
- Assignees: 3M Innovative Properties Company
- Applicants: 3M Innovative Properties Company
- Inventors: Stephen B. Roscoe; George W. Griesgraber; Tonya D. Bonilla; Giuseppe M. Bommarito; Wensheng Xia; Jeffrey M. Flynn
- Web page: https://patentgrep.com/patent/US20240307577A1

## CPC

- A61L 2/28: Devices for testing the effectiveness or completeness of sterilisation or disinfection, e.g. indicators which change colour
- A61L 2/16: using chemical substances
- C07H 17/075: Benzo[b]pyran-2-ones
- C09K 11/06: containing organic luminescent materials
- C12Q 1/22: Testing for sterility conditions
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A chlorinated 4′-alkylumbelliferyl α-D-glucopy-ranoside represented by the structural formula (I) One of R1 and R2 is Cl and the other is H. R3 represents an alkyl group having 1 to 12 carbon atoms. A method of assessing efficacy of a sterilization process including the same is also disclosed.

## Claims

### Claim 1

A chlorinated 4′-alkylumbelliferyl α-D-glucopyranoside represented by the structural formula
wherein:
one of R1 and R2 is Cl and the other is H; and
R3 represents an alkyl group having 1 to 12 carbon atoms.

### Claim 2 (depends on 1)

The chlorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1, wherein R1 is Cl and R2 is H.

### Claim 3 (depends on 1)

The chlorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1, wherein R2 is Cl and R1 is H.

### Claim 4 (depends on 1)

The chlorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1, wherein R3 has from 1 to 4 carbon atoms.

### Claim 5 (depends on 1)

The chlorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1, wherein R3 is methyl.

### Claim 6

A method of assessing efficacy of a sterilization process, the method comprising sequentially:
a) providing a biological sterilization indicator comprising:
i) bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate represented by the structural formula
wherein:
one of R1 and R2 is Cl and the other is H, and
R3 represents an alkyl group having 1 to 12 carbon atoms; and
ii) a composition, wherein the composition comprises the enzyme substrate, wherein if the composition is brought into contact with the bacterial spores to form a mixture, the mixture will have an initial pH in the range from 5.5 to 9.0;
b) subjecting at least the bacterial spores to the sterilization process;
c) contacting the composition with the bacterial spores; and
d) evaluating efficacy of the sterilization process.

### Claim 7 (depends on 6)

The method of claim 6, wherein step d) comprises fluorescence spectroscopy.

### Claim 8 (depends on 6)

The method of claim 6, wherein R1 is Cl and R2 is H.

### Claim 9 (depends on 6)

The method of claim 6, wherein R2 is Cl and R1 is H.

### Claim 10 (depends on 6)

The method of claim 6, wherein R is an alkyl group having 1 to 4 carbon atoms.

### Claim 11 (depends on 6)

The method of claim 6, wherein R is methyl.
